Valuation: Olympus Corporation

Market Cap 1,849B 11.38B 9.96B 9.18B 8.49B 16.13B 1,086B 16.41B 109B 43.01B 535B 42.75B 41.82B P/E 2027 *
19.2x
P/E 2028 * 15.9x
Enterprise Value 1,919B 11.81B 10.34B 9.52B 8.81B 16.74B 1,127B 17.03B 113B 44.64B 555B 44.36B 43.4B EV / Sales 2027 *
1.8x
EV / Sales 2028 * 1.72x
Free-Float
94.53%
Yield 2027 *
1.77%
Yield 2028 * 1.85%
1 day-1.64%
1 week+5.77%
Current month+2.47%
1 month-3.79%
3 months+8.68%
6 months-16.60%
Current year-12.27%
1 week 1,729.5
Extreme 1729.5
1,818
1 month 1,610
Extreme 1610
1,818
Current year 1,302.5
Extreme 1302.5
2,137
1 year 1,302.5
Extreme 1302.5
2,168
3 years 1,302.5
Extreme 1302.5
2,867
5 years 1,302.5
Extreme 1302.5
3,198
10 years 758.75
Extreme 758.75
3,198
Manager TitleAgeSince
Chief Executive Officer 63 2025-05-31
Director of Finance/CFO 59 2026-03-31
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 69 2023-03-31
Director/Board Member 41 2019-05-31
Director/Board Member 63 2019-05-31
Change 5-day change 1-year change 3-year change Capi.($)
-1.64%+5.77%+4.82%-21.65% 11.56B
+2.86%+2.22%+23.12%+2.14% 190B
-0.86%+2.28%-21.95%+24.23% 147B
+2.73%+1.17%-2.34%-15.92% 135B
+0.40%+4.48%-56.07%-13.96% 66.6B
-2.47%-0.72%+19.56%+1.19% 53.92B
+0.38%-0.29%-26.71%-30.66% 43.57B
+3.50%+0.15%+10.40%+14.18% 36.45B
+2.44%-0.26%+8.44%+42.77% 36.15B
+1.27%+3.65%-18.76%-3.41% 29.69B
Average +1.01%+1.84%-5.95%-0.11% 74.95B
Weighted average by Cap. +1.52%+1.71%-3.76%+1.77%

Financials

2027 *2028 *
Net sales 1,065B 6.56B 5.74B 5.29B 4.89B 9.29B 625B 9.45B 62.89B 24.78B 308B 24.62B 24.09B 1,107B 6.81B 5.96B 5.49B 5.08B 9.65B 650B 9.82B 65.33B 25.74B 320B 25.58B 25.03B
Net income 98.47B 606M 530M 489M 452M 859M 57.82B 874M 5.81B 2.29B 28.49B 2.28B 2.23B 118B 724M 633M 583M 540M 1.03B 69.03B 1.04B 6.94B 2.73B 34.02B 2.72B 2.66B
Net Debt 69.9B 430M 377M 347M 321M 610M 41.05B 620M 4.13B 1.63B 20.23B 1.62B 1.58B 51.9B 320M 280M 258M 238M 453M 30.48B 461M 3.06B 1.21B 15.02B 1.2B 1.17B
Logo Olympus Corporation
Olympus Corp is a Japan-based company mainly engaged in the manufacture and sale of endoscopes, therapeutic equipment, scientific and other products. The Company operates through three business segments. The Endoscope segment provides gastrointestinal endoscopes, surgical endoscopes, and medical services. The Therapeutic Equipment segment provides gastrointestinal treatment instruments, urology products, respiratory products, energy devices, otolaryngology products and gynecology products. The Others segment provides biomaterials and orthopedic instruments. The Company is also engaged in the business activities, including holding companies and financial investments related to each business.
Employees
28,138
Date Price Change Volume
26-07-09 ¥1,741.00 -1.64% 3,166,800
26-07-08 ¥1,770.00 -1.12% 4,558,100
26-07-07 ¥1,790.00 +1.47% 5,393,700
26-07-06 ¥1,764.00 -0.23% 2,337,100
26-07-03 ¥1,768.00 +2.91% 3,647,100
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
1,741.00JPY
Average target price
1,913.08JPY
Spread / Average Target
+9.88%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 7733 Stock